REGN price target
Regeneron Pharmaceuticals, Inc. · end-of-day data as of Oct 16, 2026
Regeneron Pharmaceuticals, Inc.
$790.74+20.7%
Buy · 29 analystsPT $859.53 +8.7%
The average price target of the 24 analyst firms that published one in the last 12 months is $859.53 for REGN, 8.7% above the last close of $790.74 on Oct 16, 2026. Targets range from $758.91 to $1,023.04, with a median of $858.83. Rating consensus: Buy.
Summary
- Target upside+8.7%
- ConsensusBuy
Analyst price targets
Low$758.91
Average$859.53
Median$858.83
High$1,023.04
Upside+8.7%
24 firms with a target in the last 12 months · last close $790.74 · as of Oct 16, 2026
Leerink Partners$8742025-12-17
Morgan Stanley$7652025-12-12
BMO Capital$8462025-12-04
Scotiabank$7592025-11-24
Truist Financial$7902025-11-24
Wells Fargo$7312025-11-20
+10 more
RBC Capital$7702026-03-02
Guggenheim$9652026-02-09
Cantor Fitzgerald$7942026-02-02
Oppenheimer$8772026-02-02
Robert W. Baird$7392026-02-02
Tudor Pickering$9242026-02-02
+9 more
Truist Financial$8282026-03-09
RBC Capital$7442026-01-27
Canaccord Genuity$8742026-05-19
Evercore ISI$8362026-05-18
Piper Sandler$7692026-05-18
RBC Capital$7172026-05-18
Truist Financial$7882026-05-18
Wolfe Research$8582026-05-18
+8 more
BMO Capital$6572026-05-18
Leerink Partners$5772026-05-18
Leerink Partners$8262026-08-17
Bernstein$7592026-08-14
Cantor Fitzgerald$8162026-07-31
Morgan Stanley$7822026-07-31
RBC Capital$7592026-07-31
Robert W. Baird$7852026-07-31
+6 more
HSBC$9042026-09-10
Guggenheim$1,0232026-08-03
Guggenheim$9982026-07-21
UBS$9782026-10-14
RBC Capital$8212026-10-08
Raymond James$9082026-10-08
Morgan Stanley$7772026-10-07
Truist Financial$7742026-10-07
Argus Research$8242026-10-01
+2 more
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 4 · Buy 15 · Hold 9 · Sell 0 · Strong sell 1